![]() |
||||||
|
![]() | Fusion Gene Summary |
![]() | Fusion Gene ORF analysis |
![]() | Fusion Genomic Features |
![]() | Fusion Protein Features |
![]() | Fusion Gene Sequence |
![]() | Fusion Gene PPI analysis |
![]() | Related Drugs |
![]() | Related Diseases |
Fusion gene:AFF3-IL1B (FusionGDB2 ID:HG3899TG3553) |
Fusion Gene Summary for AFF3-IL1B |
![]() |
Fusion gene information | Fusion gene name: AFF3-IL1B | Fusion gene ID: hg3899tg3553 | Hgene | Tgene | Gene symbol | AFF3 | IL1B | Gene ID | 3899 | 3553 |
Gene name | AF4/FMR2 family member 3 | interleukin 1 beta | |
Synonyms | LAF4|MLLT2-like | IL-1|IL1-BETA|IL1F2|IL1beta | |
Cytomap | ('AFF3')('IL1B') 2q11.2 | 2q14.1 | |
Type of gene | protein-coding | protein-coding | |
Description | AF4/FMR2 family member 3MLLT2-related proteinlymphoid nuclear protein 4lymphoid nuclear protein related to AF4protein LAF-4 | interleukin-1 betaIL-1 betacatabolininterleukin 1betapreinterleukin 1 betapro-interleukin-1-beta | |
Modification date | 20200313 | 20200329 | |
UniProtAcc | P51826 | . | |
Ensembl transtripts involved in fusion gene | ENST00000317233, ENST00000356421, ENST00000409236, ENST00000409579, ENST00000483600, | ||
Fusion gene scores | * DoF score | 17 X 13 X 7=1547 | 4 X 6 X 3=72 |
# samples | 17 | 6 | |
** MAII score | log2(17/1547*10)=-3.18586654531133 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(6/72*10)=-0.263034405833794 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: AFF3 [Title/Abstract] AND IL1B [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | AFF3(100343539)-IL1B(113594435), # samples:2 | ||
Anticipated loss of major functional domain due to fusion event. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Tgene | IL1B | GO:0000187 | activation of MAPK activity | 10748004 |
Tgene | IL1B | GO:0001934 | positive regulation of protein phosphorylation | 10748004 |
Tgene | IL1B | GO:0006954 | inflammatory response | 10748004|21147091 |
Tgene | IL1B | GO:0008284 | positive regulation of cell proliferation | 25204733 |
Tgene | IL1B | GO:0008285 | negative regulation of cell proliferation | 3493774 |
Tgene | IL1B | GO:0010575 | positive regulation of vascular endothelial growth factor production | 12958148 |
Tgene | IL1B | GO:0010628 | positive regulation of gene expression | 11090614|21559518|23817958|25327529|26687115|29384235 |
Tgene | IL1B | GO:0010718 | positive regulation of epithelial to mesenchymal transition | 25204733 |
Tgene | IL1B | GO:0019221 | cytokine-mediated signaling pathway | 10748004 |
Tgene | IL1B | GO:0030213 | hyaluronan biosynthetic process | 15100360 |
Tgene | IL1B | GO:0030335 | positive regulation of cell migration | 25204733 |
Tgene | IL1B | GO:0030730 | sequestering of triglyceride | 19032770 |
Tgene | IL1B | GO:0031663 | lipopolysaccharide-mediated signaling pathway | 21147091 |
Tgene | IL1B | GO:0032496 | response to lipopolysaccharide | 19193853 |
Tgene | IL1B | GO:0032725 | positive regulation of granulocyte macrophage colony-stimulating factor production | 20027291 |
Tgene | IL1B | GO:0032729 | positive regulation of interferon-gamma production | 10653850|20027291 |
Tgene | IL1B | GO:0032757 | positive regulation of interleukin-8 production | 19524870 |
Tgene | IL1B | GO:0034116 | positive regulation of heterotypic cell-cell adhesion | 15100360 |
Tgene | IL1B | GO:0035505 | positive regulation of myosin light chain kinase activity | 18390750 |
Tgene | IL1B | GO:0035690 | cellular response to drug | 19158679 |
Tgene | IL1B | GO:0042102 | positive regulation of T cell proliferation | 1919436 |
Tgene | IL1B | GO:0043122 | regulation of I-kappaB kinase/NF-kappaB signaling | 10748004 |
Tgene | IL1B | GO:0045429 | positive regulation of nitric oxide biosynthetic process | 8383325 |
Tgene | IL1B | GO:0045766 | positive regulation of angiogenesis | 25204733 |
Tgene | IL1B | GO:0045893 | positive regulation of transcription, DNA-templated | 15100360 |
Tgene | IL1B | GO:0050796 | regulation of insulin secretion | 8383325 |
Tgene | IL1B | GO:0050995 | negative regulation of lipid catabolic process | 19032770 |
Tgene | IL1B | GO:0050999 | regulation of nitric-oxide synthase activity | 15899045 |
Tgene | IL1B | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis | 18373975 |
Tgene | IL1B | GO:0051091 | positive regulation of DNA-binding transcription factor activity | 10748004 |
Tgene | IL1B | GO:0051092 | positive regulation of NF-kappaB transcription factor activity | 10383454|12958148|25327529 |
Tgene | IL1B | GO:0060559 | positive regulation of calcidiol 1-monooxygenase activity | 16720713|17023519 |
Tgene | IL1B | GO:0070372 | regulation of ERK1 and ERK2 cascade | 25204733 |
Tgene | IL1B | GO:0070487 | monocyte aggregation | 15100360 |
Tgene | IL1B | GO:0070498 | interleukin-1-mediated signaling pathway | 25327529 |
Tgene | IL1B | GO:0070555 | response to interleukin-1 | 29441883 |
Tgene | IL1B | GO:0071310 | cellular response to organic substance | 19158679 |
Tgene | IL1B | GO:0071407 | cellular response to organic cyclic compound | 21147091 |
Tgene | IL1B | GO:0071639 | positive regulation of monocyte chemotactic protein-1 production | 19524870 |
Tgene | IL1B | GO:1901224 | positive regulation of NIK/NF-kappaB signaling | 18390750 |
Tgene | IL1B | GO:1902680 | positive regulation of RNA biosynthetic process | 29384235 |
Tgene | IL1B | GO:1903140 | regulation of establishment of endothelial barrier | 25816133 |
Tgene | IL1B | GO:1903597 | negative regulation of gap junction assembly | 11090614 |
Tgene | IL1B | GO:2000556 | positive regulation of T-helper 1 cell cytokine production | 10653850 |
Tgene | IL1B | GO:2001240 | negative regulation of extrinsic apoptotic signaling pathway in absence of ligand | 10748004 |
![]() * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | PRAD | TCGA-XJ-A9DI-01A | AFF3 | chr2 | 100343539 | - | IL1B | chr2 | 113594435 | - |
ChimerDB4 | PRAD | TCGA-XJ-A9DI | AFF3 | chr2 | 100343539 | - | IL1B | chr2 | 113594435 | - |
Top |
Fusion Gene ORF analysis for AFF3-IL1B |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5CDS-5UTR | ENST00000317233 | ENST00000263341 | AFF3 | chr2 | 100343539 | - | IL1B | chr2 | 113594435 | - |
5CDS-5UTR | ENST00000356421 | ENST00000263341 | AFF3 | chr2 | 100343539 | - | IL1B | chr2 | 113594435 | - |
5CDS-5UTR | ENST00000409236 | ENST00000263341 | AFF3 | chr2 | 100343539 | - | IL1B | chr2 | 113594435 | - |
5CDS-5UTR | ENST00000409579 | ENST00000263341 | AFF3 | chr2 | 100343539 | - | IL1B | chr2 | 113594435 | - |
5CDS-intron | ENST00000317233 | ENST00000491056 | AFF3 | chr2 | 100343539 | - | IL1B | chr2 | 113594435 | - |
5CDS-intron | ENST00000356421 | ENST00000491056 | AFF3 | chr2 | 100343539 | - | IL1B | chr2 | 113594435 | - |
5CDS-intron | ENST00000409236 | ENST00000491056 | AFF3 | chr2 | 100343539 | - | IL1B | chr2 | 113594435 | - |
5CDS-intron | ENST00000409579 | ENST00000491056 | AFF3 | chr2 | 100343539 | - | IL1B | chr2 | 113594435 | - |
intron-5UTR | ENST00000483600 | ENST00000263341 | AFF3 | chr2 | 100343539 | - | IL1B | chr2 | 113594435 | - |
intron-intron | ENST00000483600 | ENST00000491056 | AFF3 | chr2 | 100343539 | - | IL1B | chr2 | 113594435 | - |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
Top |
Fusion Genomic Features for AFF3-IL1B |
![]() |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
Top |
Fusion Protein Features for AFF3-IL1B |
![]() Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/:100343539/:113594435) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
![]() |
![]() |
Hgene | Tgene |
AFF3 | . |
FUNCTION: Putative transcription activator that may function in lymphoid development and oncogenesis. Binds, in vitro, to double-stranded DNA. | FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
Fusion Gene Sequence for AFF3-IL1B |
![]() |
Top |
Fusion Gene PPI Analysis for AFF3-IL1B |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for AFF3-IL1B |
![]() (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for AFF3-IL1B |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | AFF3 | C0003873 | Rheumatoid Arthritis | 2 | CTD_human |
Hgene | AFF3 | C0013146 | Drug abuse | 1 | CTD_human |
Hgene | AFF3 | C0013170 | Drug habituation | 1 | CTD_human |
Hgene | AFF3 | C0013222 | Drug Use Disorders | 1 | CTD_human |
Hgene | AFF3 | C0029231 | Organic Mental Disorders, Substance-Induced | 1 | CTD_human |
Hgene | AFF3 | C0036572 | Seizures | 1 | GENOMICS_ENGLAND |
Hgene | AFF3 | C0038580 | Substance Dependence | 1 | CTD_human |
Hgene | AFF3 | C0038586 | Substance Use Disorders | 1 | CTD_human |
Hgene | AFF3 | C0236969 | Substance-Related Disorders | 1 | CTD_human |
Hgene | AFF3 | C0740858 | Substance abuse problem | 1 | CTD_human |
Hgene | AFF3 | C1510472 | Drug Dependence | 1 | CTD_human |
Hgene | AFF3 | C3714756 | Intellectual Disability | 1 | GENOMICS_ENGLAND |
Hgene | AFF3 | C4316881 | Prescription Drug Abuse | 1 | CTD_human |
Tgene | C0021368 | Inflammation | 9 | CTD_human | |
Tgene | C0020429 | Hyperalgesia | 6 | CTD_human | |
Tgene | C0458247 | Allodynia | 6 | CTD_human | |
Tgene | C0751211 | Hyperalgesia, Primary | 6 | CTD_human | |
Tgene | C0751212 | Hyperalgesia, Secondary | 6 | CTD_human | |
Tgene | C0751213 | Tactile Allodynia | 6 | CTD_human | |
Tgene | C0751214 | Hyperalgesia, Thermal | 6 | CTD_human | |
Tgene | C2936719 | Mechanical Allodynia | 6 | CTD_human | |
Tgene | C0005586 | Bipolar Disorder | 5 | PSYGENET | |
Tgene | C0011570 | Mental Depression | 5 | PSYGENET | |
Tgene | C0011581 | Depressive disorder | 5 | PSYGENET | |
Tgene | C0015967 | Fever | 5 | CTD_human | |
Tgene | C0035126 | Reperfusion Injury | 5 | CTD_human | |
Tgene | C0041696 | Unipolar Depression | 5 | PSYGENET | |
Tgene | C1269683 | Major Depressive Disorder | 5 | PSYGENET | |
Tgene | C0001973 | Alcoholic Intoxication, Chronic | 4 | PSYGENET | |
Tgene | C0003865 | Arthritis, Adjuvant-Induced | 4 | CTD_human | |
Tgene | C0007786 | Brain Ischemia | 4 | CTD_human | |
Tgene | C0009324 | Ulcerative Colitis | 4 | CTD_human | |
Tgene | C0917798 | Cerebral Ischemia | 4 | CTD_human | |
Tgene | C0971858 | Arthritis, Collagen-Induced | 4 | CTD_human | |
Tgene | C0993582 | Arthritis, Experimental | 4 | CTD_human | |
Tgene | C0003873 | Rheumatoid Arthritis | 3 | CTD_human | |
Tgene | C0006142 | Malignant neoplasm of breast | 3 | CTD_human | |
Tgene | C0007102 | Malignant tumor of colon | 3 | CTD_human | |
Tgene | C0009375 | Colonic Neoplasms | 3 | CTD_human | |
Tgene | C0020538 | Hypertensive disease | 3 | CTD_human | |
Tgene | C0024623 | Malignant neoplasm of stomach | 3 | CTD_human | |
Tgene | C0027051 | Myocardial Infarction | 3 | CTD_human | |
Tgene | C0027540 | Necrosis | 3 | CTD_human | |
Tgene | C0038356 | Stomach Neoplasms | 3 | CTD_human | |
Tgene | C0678222 | Breast Carcinoma | 3 | CTD_human | |
Tgene | C1257931 | Mammary Neoplasms, Human | 3 | CTD_human | |
Tgene | C1458155 | Mammary Neoplasms | 3 | CTD_human | |
Tgene | C1708349 | Hereditary Diffuse Gastric Cancer | 3 | CTD_human | |
Tgene | C4704874 | Mammary Carcinoma, Human | 3 | CTD_human | |
Tgene | C0009319 | Colitis | 2 | CTD_human | |
Tgene | C0017658 | Glomerulonephritis | 2 | CTD_human | |
Tgene | C0019193 | Hepatitis, Toxic | 2 | CTD_human | |
Tgene | C0020649 | Hypotension | 2 | CTD_human | |
Tgene | C0024121 | Lung Neoplasms | 2 | CTD_human | |
Tgene | C0026769 | Multiple Sclerosis | 2 | CTD_human | |
Tgene | C0034069 | Pulmonary Fibrosis | 2 | CTD_human | |
Tgene | C0037274 | Dermatologic disorders | 2 | CTD_human | |
Tgene | C0242379 | Malignant neoplasm of lung | 2 | CTD_human | |
Tgene | C0751324 | Multiple Sclerosis, Acute Fulminating | 2 | CTD_human | |
Tgene | C0860207 | Drug-Induced Liver Disease | 2 | CTD_human | |
Tgene | C1262760 | Hepatitis, Drug-Induced | 2 | CTD_human | |
Tgene | C1704377 | Bright Disease | 2 | CTD_human | |
Tgene | C3658290 | Drug-Induced Acute Liver Injury | 2 | CTD_human | |
Tgene | C4277682 | Chemical and Drug Induced Liver Injury | 2 | CTD_human | |
Tgene | C4279912 | Chemically-Induced Liver Toxicity | 2 | CTD_human | |
Tgene | C4721507 | Alveolitis, Fibrosing | 2 | CTD_human | |
Tgene | C0000786 | Spontaneous abortion | 1 | CTD_human | |
Tgene | C0000822 | Abortion, Tubal | 1 | CTD_human | |
Tgene | C0001418 | Adenocarcinoma | 1 | CTD_human | |
Tgene | C0002152 | Alloxan Diabetes | 1 | CTD_human | |
Tgene | C0002395 | Alzheimer's Disease | 1 | CTD_human | |
Tgene | C0003123 | Anorexia | 1 | CTD_human | |
Tgene | C0003165 | Anthracosis | 1 | CTD_human | |
Tgene | C0004096 | Asthma | 1 | CTD_human | |
Tgene | C0005398 | Cholestasis, Extrahepatic | 1 | CTD_human | |
Tgene | C0006287 | Bronchopulmonary Dysplasia | 1 | CTD_human | |
Tgene | C0006663 | Calcinosis | 1 | CTD_human | |
Tgene | C0006826 | Malignant Neoplasms | 1 | CTD_human | |
Tgene | C0011265 | Presenile dementia | 1 | CTD_human | |
Tgene | C0011615 | Dermatitis, Atopic | 1 | CTD_human | |
Tgene | C0011633 | Dermatomyositis | 1 | CTD_human | |
Tgene | C0011853 | Diabetes Mellitus, Experimental | 1 | CTD_human | |
Tgene | C0014324 | Entamoebiasis | 1 | CTD_human | |
Tgene | C0016059 | Fibrosis | 1 | CTD_human | |
Tgene | C0017154 | Gastritis, Atrophic | 1 | CTD_human | |
Tgene | C0017636 | Glioblastoma | 1 | CTD_human | |
Tgene | C0018099 | Gout | 1 | CTD_human | |
Tgene | C0018800 | Cardiomegaly | 1 | CTD_human | |
Tgene | C0018801 | Heart failure | 1 | CTD_human | |
Tgene | C0018802 | Congestive heart failure | 1 | CTD_human | |
Tgene | C0018824 | Heart valve disease | 1 | CTD_human | |
Tgene | C0019061 | Hemolytic-Uremic Syndrome | 1 | CTD_human | |
Tgene | C0020452 | Hyperemia | 1 | CTD_human | |
Tgene | C0020517 | Hypersensitivity | 1 | CTD_human | |
Tgene | C0020615 | Hypoglycemia | 1 | CTD_human | |
Tgene | C0022333 | Jacksonian Seizure | 1 | CTD_human | |
Tgene | C0022541 | Kearns-Sayre syndrome | 1 | CTD_human | |
Tgene | C0023186 | Learning Disorders | 1 | CTD_human | |
Tgene | C0023212 | Left-Sided Heart Failure | 1 | CTD_human | |
Tgene | C0023283 | Leishmaniasis, Cutaneous | 1 | CTD_human | |
Tgene | C0023290 | Leishmaniasis, Visceral | 1 | CTD_human | |
Tgene | C0023380 | Lethargy | 1 | CTD_human | |
Tgene | C0023518 | Leukocytosis | 1 | CTD_human | |
Tgene | C0023893 | Liver Cirrhosis, Experimental | 1 | CTD_human | |
Tgene | C0024312 | Lymphopenia | 1 | CTD_human | |
Tgene | C0024799 | Marginal ulcer | 1 | CTD_human | |
Tgene | C0024809 | Marijuana Abuse | 1 | PSYGENET | |
Tgene | C0025261 | Memory Disorders | 1 | CTD_human | |
Tgene | C0026848 | Myopathy | 1 | CTD_human | |
Tgene | C0027626 | Neoplasm Invasiveness | 1 | CTD_human | |
Tgene | C0027651 | Neoplasms | 1 | CTD_human | |
Tgene | C0027947 | Neutropenia | 1 | CTD_human | |
Tgene | C0029408 | Degenerative polyarthritis | 1 | CTD_human | |
Tgene | C0029458 | Osteoporosis, Postmenopausal | 1 | CTD_human | |
Tgene | C0030246 | Pustulosis of Palms and Soles | 1 | CTD_human | |
Tgene | C0030920 | Peptic Ulcer | 1 | CTD_human | |
Tgene | C0032231 | Pleurisy | 1 | CTD_human | |
Tgene | C0032285 | Pneumonia | 1 | CTD_human | |
Tgene | C0032300 | Lobar Pneumonia | 1 | CTD_human | |
Tgene | C0033141 | Cardiomyopathies, Primary | 1 | CTD_human | |
Tgene | C0033860 | Psoriasis | 1 | CTD_human | |
Tgene | C0036341 | Schizophrenia | 1 | CTD_human | |
Tgene | C0036529 | Myocardial Diseases, Secondary | 1 | CTD_human | |
Tgene | C0036572 | Seizures | 1 | CTD_human | |
Tgene | C0037116 | Silicosis | 1 | CTD_human | |
Tgene | C0038358 | Gastric ulcer | 1 | CTD_human | |
Tgene | C0038433 | Streptozotocin Diabetes | 1 | CTD_human | |
Tgene | C0038454 | Cerebrovascular accident | 1 | CTD_human | |
Tgene | C0040136 | Thyroid Neoplasm | 1 | CTD_human | |
Tgene | C0040997 | Trigeminal Neuralgia | 1 | CTD_human | |
Tgene | C0042109 | Urticaria | 1 | CTD_human | |
Tgene | C0042484 | Venous Engorgement | 1 | CTD_human | |
Tgene | C0085655 | Polymyositis | 1 | CTD_human | |
Tgene | C0086196 | Eczema, Infantile | 1 | CTD_human | |
Tgene | C0086540 | Leishmaniasis, New World | 1 | CTD_human | |
Tgene | C0086541 | Urban cutaneous leishmaniasis | 1 | CTD_human | |
Tgene | C0086692 | Benign Neoplasm | 1 | CTD_human | |
Tgene | C0086743 | Osteoarthrosis Deformans | 1 | CTD_human | |
Tgene | C0149958 | Complex partial seizures | 1 | CTD_human | |
Tgene | C0151468 | Thyroid Gland Follicular Adenoma | 1 | CTD_human | |
Tgene | C0151744 | Myocardial Ischemia | 1 | CTD_human | |
Tgene | C0151857 | Pleocytosis | 1 | CTD_human | |
Tgene | C0162668 | Megaconial Myopathies | 1 | CTD_human | |
Tgene | C0162669 | Pleoconial Myopathies | 1 | CTD_human | |
Tgene | C0162670 | Mitochondrial Myopathies | 1 | CTD_human | |
Tgene | C0162671 | MELAS Syndrome | 1 | CTD_human | |
Tgene | C0162672 | MERRF Syndrome | 1 | CTD_human | |
Tgene | C0162674 | Chronic progressive external ophthalmoplegia | 1 | CTD_human | |
Tgene | C0178824 | Reactive Hyperemia | 1 | CTD_human | |
Tgene | C0205641 | Adenocarcinoma, Basal Cell | 1 | CTD_human | |
Tgene | C0205642 | Adenocarcinoma, Oxyphilic | 1 | CTD_human | |
Tgene | C0205643 | Carcinoma, Cribriform | 1 | CTD_human | |
Tgene | C0205644 | Carcinoma, Granular Cell | 1 | CTD_human | |
Tgene | C0205645 | Adenocarcinoma, Tubular | 1 | CTD_human | |
Tgene | C0221056 | Adult type dermatomyositis | 1 | CTD_human | |
Tgene | C0233794 | Memory impairment | 1 | CTD_human | |
Tgene | C0234533 | Generalized seizures | 1 | CTD_human | |
Tgene | C0234535 | Clonic Seizures | 1 | CTD_human | |
Tgene | C0235527 | Heart Failure, Right-Sided | 1 | CTD_human | |
Tgene | C0238281 | Middle Cerebral Artery Syndrome | 1 | CTD_human | |
Tgene | C0263628 | Tumoral calcinosis | 1 | CTD_human | |
Tgene | C0263666 | Dermatomyositis, Childhood Type | 1 | CTD_human | |
Tgene | C0263984 | Polymyositis Ossificans | 1 | CTD_human | |
Tgene | C0270824 | Visual seizure | 1 | CTD_human | |
Tgene | C0270844 | Tonic Seizures | 1 | CTD_human | |
Tgene | C0270846 | Epileptic drop attack | 1 | CTD_human | |
Tgene | C0271708 | Fasting Hypoglycemia | 1 | CTD_human | |
Tgene | C0271710 | Reactive hypoglycemia | 1 | CTD_human | |
Tgene | C0274861 | Arsenic Poisoning, Inorganic | 1 | CTD_human | |
Tgene | C0274862 | Nervous System, Organic Arsenic Poisoning | 1 | CTD_human | |
Tgene | C0276496 | Familial Alzheimer Disease (FAD) | 1 | CTD_human | |
Tgene | C0311375 | Arsenic Poisoning | 1 | CTD_human | |
Tgene | C0333233 | Active Hyperemia | 1 | CTD_human | |
Tgene | C0333355 | Inflammatory disease of mucous membrane | 1 | CTD_human | |
Tgene | C0334588 | Giant Cell Glioblastoma | 1 | CTD_human | |
Tgene | C0343755 | HIV Wasting Syndrome | 1 | CTD_human | |
Tgene | C0393786 | Trigeminal Neuralgia, Idiopathic | 1 | CTD_human | |
Tgene | C0393787 | Secondary Trigeminal Neuralgia | 1 | CTD_human | |
Tgene | C0422850 | Seizures, Somatosensory | 1 | CTD_human | |
Tgene | C0422852 | Seizures, Auditory | 1 | CTD_human | |
Tgene | C0422853 | Olfactory seizure | 1 | CTD_human | |
Tgene | C0422854 | Gustatory seizure | 1 | CTD_human | |
Tgene | C0422855 | Vertiginous seizure | 1 | CTD_human | |
Tgene | C0494463 | Alzheimer Disease, Late Onset | 1 | CTD_human | |
Tgene | C0494475 | Tonic - clonic seizures | 1 | CTD_human | |
Tgene | C0521174 | Microcalcification | 1 | CTD_human | |
Tgene | C0546126 | Acute Confusional Senile Dementia | 1 | CTD_human | |
Tgene | C0549473 | Thyroid carcinoma | 1 | CTD_human | |
Tgene | C0554591 | Polymyositis, Idiopathic | 1 | CTD_human | |
Tgene | C0677050 | Manganese Poisoning | 1 | CTD_human | |
Tgene | C0740376 | Middle Cerebral Artery Thrombosis | 1 | CTD_human | |
Tgene | C0740391 | Middle Cerebral Artery Occlusion | 1 | CTD_human | |
Tgene | C0740392 | Infarction, Middle Cerebral Artery | 1 | CTD_human | |
Tgene | C0750900 | Alzheimer's Disease, Focal Onset | 1 | CTD_human | |
Tgene | C0750901 | Alzheimer Disease, Early Onset | 1 | CTD_human | |
Tgene | C0751056 | Non-epileptic convulsion | 1 | CTD_human | |
Tgene | C0751110 | Single Seizure | 1 | CTD_human | |
Tgene | C0751123 | Atonic Absence Seizures | 1 | CTD_human | |
Tgene | C0751262 | Adult Learning Disorders | 1 | CTD_human | |
Tgene | C0751263 | Learning Disturbance | 1 | CTD_human | |
Tgene | C0751265 | Learning Disabilities | 1 | CTD_human | |
Tgene | C0751292 | Age-Related Memory Disorders | 1 | CTD_human | |
Tgene | C0751293 | Memory Disorder, Semantic | 1 | CTD_human | |
Tgene | C0751294 | Memory Disorder, Spatial | 1 | CTD_human | |
Tgene | C0751295 | Memory Loss | 1 | CTD_human | |
Tgene | C0751494 | Convulsive Seizures | 1 | CTD_human | |
Tgene | C0751495 | Seizures, Focal | 1 | CTD_human | |
Tgene | C0751496 | Seizures, Sensory | 1 | CTD_human | |
Tgene | C0751508 | Long Sleeper Syndrome | 1 | CTD_human | |
Tgene | C0751509 | Short Sleeper Syndrome | 1 | CTD_human | |
Tgene | C0751510 | Sleep-Related Neurogenic Tachypnea | 1 | CTD_human | |
Tgene | C0751511 | Subwakefullness Syndrome | 1 | CTD_human | |
Tgene | C0751845 | Middle Cerebral Artery Embolus | 1 | CTD_human | |
Tgene | C0751846 | Left Middle Cerebral Artery Infarction | 1 | CTD_human | |
Tgene | C0751847 | Embolic Infarction, Middle Cerebral Artery | 1 | CTD_human | |
Tgene | C0751848 | Thrombotic Infarction, Middle Cerebral Artery | 1 | CTD_human | |
Tgene | C0751849 | Right Middle Cerebral Artery Infarction | 1 | CTD_human | |
Tgene | C0751851 | Arsenic Encephalopathy | 1 | CTD_human | |
Tgene | C0751852 | Arsenic Induced Polyneuropathy | 1 | CTD_human | |
Tgene | C0751956 | Acute Cerebrovascular Accidents | 1 | CTD_human | |
Tgene | C0851578 | Sleep Disorders | 1 | CTD_human | |
Tgene | C0878544 | Cardiomyopathies | 1 | CTD_human | |
Tgene | C0887898 | Experimental Lung Inflammation | 1 | CTD_human | |
Tgene | C0917796 | Optic Atrophy, Hereditary, Leber | 1 | CTD_human | |
Tgene | C0949496 | Luft Disease | 1 | CTD_human | |
Tgene | C1330966 | Developmental Academic Disorder | 1 | CTD_human | |
Tgene | C1383860 | Cardiac Hypertrophy | 1 | CTD_human | |
Tgene | C1527304 | Allergic Reaction | 1 | CTD_human | |
Tgene | C1621958 | Glioblastoma Multiforme | 1 | CTD_human | |
Tgene | C1623038 | Cirrhosis | 1 | CTD_human | |
Tgene | C1858361 | Pyogenic Arthritis, Pyoderma Gangrenosum and Acne | 1 | CTD_human | |
Tgene | C1959583 | Myocardial Failure | 1 | CTD_human | |
Tgene | C1961112 | Heart Decompensation | 1 | CTD_human | |
Tgene | C3495874 | Nonepileptic Seizures | 1 | CTD_human | |
Tgene | C3714636 | Pneumonitis | 1 | CTD_human | |
Tgene | C3830362 | Early Pregnancy Loss | 1 | CTD_human | |
Tgene | C4042891 | Sleep Wake Disorders | 1 | CTD_human | |
Tgene | C4048158 | Convulsions | 1 | CTD_human | |
Tgene | C4316791 | Entamoeba histolytica Infection | 1 | CTD_human | |
Tgene | C4316903 | Absence Seizures | 1 | CTD_human | |
Tgene | C4317109 | Epileptic Seizures | 1 | CTD_human | |
Tgene | C4317123 | Myoclonic Seizures | 1 | CTD_human | |
Tgene | C4505436 | Generalized Absence Seizures | 1 | CTD_human | |
Tgene | C4552766 | Miscarriage | 1 | CTD_human |